- 2023 CPG – Guideline for the management of fatigue in children and adolescents with cancer or pediatric hematopoietic cell transplant recipients: 2023 Update (open access at eClinicalMedicine) NEW
- Endorsed by the Multinational Association of Supportive Care in Cancer (MASCC)
- Archived 2018 CPG – Management of fatigue in children and adolescents with cancer and in paediatric recipients of haemopoietic stem-cell transplants: a clinical practice guideline (The Lancet Child & Adolescent Health – free access available with registration)
- Read the accepted Word version here.
- Endorsed by the Children’s Oncology Group (COG)
- 2017 SR – Mind and body practices for fatigue reduction in patients with cancer and hematopoietic stem cell transplant recipients: A systematic review and meta-analysis (Critical Reviews in Oncology/Hematology – not available as open access)
- 2018 Meta-analysis – Pharmacologic interventions for fatigue in cancer and transplantation: a meta-analysis (open access at Current Oncology)
- 2018 SR – Physical activity reduces fatigue in patients with cancer and hematopoietic stem cell transplant recipients: A systematic review and meta-analysis of randomized trials (Critical Reviews in Oncology/Hematology – not available as open access)
If you have any questions about any of the POGO guidelines, our development processes or guidelines under development, please email:
Paula Robinson, MD, MSc
Senior Manager, Supportive Care and Guidelines
Related Articles
Virtual Learning When You Have ADHD
August 29, 2022
From the Perspective of a Childhood Cancer Survivor - Leigha Bartholomew
Doing Good for the Childhood Cancer and Survivor Community
August 29, 2022
Austin: What was it like battling cancer as a young teen? Eloise: I was 14 years old when I was…
Patients and families tell their stories through their eyes
August 18, 2022
To quote Brené Brown, “Maybe stories are just data with a soul.” It is POGO’s hope that everyone…
Welcome to our New Corporate Partner
June 5, 2022
We are thrilled to announce that in November 2022, Desjardins made a three-year commitment of…
Antibacterial ProphylaxisAntifungal ProphylaxisChemotherapy-Induced Nausea & VomitingAcute delayed Phase CINVAnticipatory CINVBreakthrough & Refractory CINVEmetogenicity ClassificationAcute & Delayed Phase CINVChronic Pain*Clostridium Difficile InfectionFatigueFertility Preservation*MucositisOtotoxicityFever and NeutropeniaPlatelet Transfusion*Venous Thromboembolism*
Care Pathways


YOU can be a champion for kids with cancer!
With your help, we will ensure that kids and youth with cancer, their families and survivors of childhood cancer have equitable access to the best care for the best possible outcomes.